At meeting held on 03 February 2021
The Board of Solara Active Pharma Sciences at its meeting held on 03 February 2021 has approved the acquisition of additional share capital in Sequent Penems (SPPL), subsidiary company of Solara.Currently Solara holds 89.23% of SPPL and it is proposed to acquire remaining 10.77% to make it as a wholly owned subsidiary.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
